TipRanks
Evgen Pharma PLC (GB:TCF)
LSE:TCF
UK Market
TCF
Evgen Pharma
RESEARCH TOOLSreports
Want to see GB:TCF full AI Analyst Report?

Evgen Pharma (TCF) Income Statement

4 Followers

Evgen Pharma Income Statement

Last quarter (Q4 2025), Evgen Pharma's total revenue was £0.00, a decrease of ― from the same quarter last year. In Q4, Evgen Pharma's net income was £-2.22M. See Evgen Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
£ 0.00£ 0.00£ 396.00K£ 442.00K£ 0.00
Gross Profit
£ -16.00K£ -2.11M£ 385.00K£ 429.00K£ -16.00K
Operating Expenses
£ 3.67M£ 12.00K£ 3.94M£ 5.50M£ 3.17M
Depreciation and Amortization
£ 16.00K£ 69.00K£ 11.00K£ 13.00K£ 16.00K
EBITDA
£ -3.67M£ -2.06M£ -3.55M£ -4.99M£ -3.15M
Operating Income
£ -3.69M£ -2.12M£ -3.56M£ -5.07M£ -3.19M
Other Income/Expenses
£ 117.00K£ 39.00K£ -6.00K£ 98.00K£ 22.00K
Pretax Income
£ -3.57M£ -2.08M£ -3.57M£ -5.01M£ -3.17M
Net Income
£ -3.53M£ -1.94M£ -3.14M£ -4.04M£ -2.73M
Per Share Metrics
Basic EPS
£ >-0.01£ >-0.01£ -0.01£ -0.01£ -0.01
Diluted EPS
£ >-0.01£ >-0.01£ -0.01£ -0.01£ -0.01
Weighted Average Shares Outstanding
 2.15B 538.31M 274.89M 274.89M 274.89M
Weighted Average Shares Outstanding (Diluted)
 2.15B 538.31M 274.89M 274.89M 274.89M
Currency in GBP

Evgen Pharma Earnings and Revenue History